Young Investigator Award winners

These annual EAS prizes for young scientists are intended to recognise distinction shown by publications that contribute to the advancement of knowledge in the field of atherosclerosis and linked metabolic disturbances. Each prize is of € 2,000. 

Call for nominations for the 2022 award is open! Deadline to submit a nomination is February 02, 2023 >


Previous Award winners

The winners of the annual Young Investigator Awards for outstanding publications during 2021

Congratulations to:

Dimitris Tsiantoulas

Basic Science Award

  • Article: APRIL limits atherosclerosis by binding to heparan sulphate proteoglycans
  • Published in: Nature volume 597, pages 92–96 (2021) 
    DOI: 10.1038/s41586-021-03818-3
  • Author: Dimitris Tsiantoulas, Medical University of Vienna

    Dimitrios Tsiantoulas completed his PhD studies in Christoph Binder’s group at the Medical University of Vienna and at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences. After graduating, he worked as a post-doc, funded by the British Heart Foundation, in Ziad Mallat’s group at the University of Cambridge. He is currently a research group leader at the Medical University of Vienna. His research aims to dissect the molecular machinery that governs the functions of APRIL and B cells in atherosclerosis and myocardial infarction.

Amand F. Schmidt

Clinical Science Award

  • Article: Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease
  • Published in: Nature Communications volume 12, Article number: 5640 (2021)
    DOI: 10.1038/s41467-021-25703-3 
  • Author: Amand F. Schmidt, UCL, London

    A. Floriaan Schmidt has received training in public health, clinical epidemiology, and mathematics. Floriaan completed a PhD on methods for personalized medicine with the Utrecht University in the Netherlands. Following his PhD, he accepted a position with University College London. Here Floriaan developed the necessary mathematical framework underpinning the principles of drug target validation using human genetics (Nature Communications 2021).

    Dr Schmidt is a Senior Research Follow with the Institute of Cardiovascular Science at UCL, and holds an Associate Professorship with the Heart and Lungs department at UMC Utrecht in the Netherlands. Floriaan received funding from the British Heart Foundation, the National Institute for Health Research University College London Hospitals Biomedical Research Centre, Servier and Erasmus+.

Acknowledgement and thanks

The Society is grateful to the members of the Award Committee, Chaired by Prof Ruth Frikke-Schmidt & Prof Zeljko Reiner, who gave their time and expertise in the review and evaluation of the nominations received for these awards. There were many nominations of a very high standard – an encouraging sign for the future of research in the field!


Winners of the Young Investigator Awards for outstanding publications during 2020

Anna Wolska

Basic Science Award 2020

  • Article: A dual apolipoprotein C-II mimetic – apolipoprotein C-III antagonist peptide lowers plasma triglycerides. 
  • Published in: Science Translational Medicine, Sci Transl Med 2020, 12(528): eaaw7905. DOI: 10.1126/scitranslmed.aaw7905
  • Author: Anna Wolska

    Anna Wolska is a researcher in projects related to new methods for estimation of lipids/lipoproteins in diagnostics and atherosclerotic cardiovascular disease risk.
    She is also lead researcher, along with industrial collaborators, on projects focused on mimetic peptides as potential therapies for hypertriglyceridemia. Co-inventor on U.S. patents related to the therapeutic use of apolipoprotein C-II mimetic peptides.
Ida Juul Rasmussen

Clinical Science Award 2020

  • Article: Impact of cardiovascular risk factors and genetics on 10-year absolute risk of dementia: risk charts for targeted prevention.
  • Published in: European Heart Journal, Eur Heart J 2020;41:4024-4033.
    DOI:10.1093/eurheartj/ehaa695
  • Author: Ida Juul Rasmussen

    Ida Juul Rasmussen was born in 1984 in Copenhagen, Denmark. She is MD, PhD from the University of Copenhagen. She is currently in clinical training in Clinical Biochemistry where she pursues translational research with special focus on the vascular parts of dementia by integrating modifiable atherogenic risk factors, blood biomarkers and genetics in identification of high-risk groups for targeted prevention of dementia.

Winners of the Young Investigator Awards for outstanding publications during 2019

Thimoteus Speer

Basic Science Award 2019

  • Article: Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation.
  • Published in: Nature Immunology.
    https://www.nature.com/articles/s41590-019-0548-1
  • Author: Thimoteus Speer
Antoine Rimbert & Nawar Dalila

Clinical Science Award

  • Article: A common variant in CCDC93 protects against myocardial infarction and cardiovascular mortality by regulating endosomal trafficking of low-density lipoprotein receptor.
  • Published in: European Heart Journal. 2019 Oct 19. pii: ehz727.
    DOI: 10.1093/eurheartj/ehz727
  • Authors (joint first authors): Antoine Rimbert and Nawar Dalila

About the winners and their papers

The Basic Science winner, Timo Speer, was born 1981 in Zweibrücken, Germany. He is Head of Experimental and Translational Nephrology at Sarland University in Homburg, Germany. He has a longstanding translational interest in the importance of lipid biology for inflammatory mechanisms in cardiovascular and renal diseases. His strength is to bring together cutting edge technologies and scientists from basic science, genetics, lipidology, cardiology, immunology and his home-base, nephrology.

The data in his Award-winning paper reveal a novel and important link between triglyceride-rich lipoproteins and vascular inflammation. Using molecular methodology, animal models and human studies, Timo Speer´s paper shows that apolipoprotein C3 (ApoC3) activates the NLRP3 inflammasome in human monocytes by inducing an alternative NLRP3 inflammasome via caspase-8 and dimerization of Toll-like receptors 2 and 4. Alternative inflammasome activation in human monocytes is mediated by the Toll-like receptor adapter protein SCIMP. This triggers Lyn/Syk-dependent calcium entry and the production of reactive oxygen species, leading to activation of caspase-8. In humanized mouse models, ApoC3 activated human monocytes in vivo to impede endothelial regeneration and promote kidney injury in an NLRP3- and caspase-8-dependent manner.

These data provide new insights into the regulation of the NLRP3 inflammasome and the pathophysiological role of triglyceride-rich lipoproteins containing ApoC3. As potential clinical consequence, Timo Speer’s work suggests that targeting ApoC3 might prevent organ damage and provide an anti-inflammatory treatment for vascular and kidney diseases.

The Clinical Science award-winning paper, with joint first authors Antoine Rimbert and Nawar Dalila, is on the subject of an intracellular process – almost exclusively studied by cellular biologists to date – in regulating plasma lipid levels and its effects on atherosclerosis in humans. The results show for the first time that endosomal recycling of lipoprotein receptors in the liver affects plasma levels of cholesterol and thereby risk of myocardial infarction and cardiovascular morbidity. 

The first authors of this study have been mutually dependent on making this study possible.

Acknowledgement and thanks

The Society is grateful to the members of the Award Committee 2016-2020, Chaired by Prof Petri Kovanen & Prof Christoph Binder, and additional reviewers who gave their time and expertise in the review and evaluation of the nominations received for these awards.